Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-02-05

EMA Authorised: Clopidogrel Zentiva (previously Clopidogrel Winthrop) (clopidogrel) — Zentiva k.s.

View source ↗

Summary

The European Medicines Agency authorised Zentiva’s generic clopidogrel product for prevention of stroke, myocardial infarction, acute coronary syndrome, and rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clopidogrel Zentiva (clopidogrel)

Snippet

Status: Authorised. Therapeutic area: Stroke;Peripheral Vascular Diseases;Myocardial Infarction;Acute Coronary Syndrome. MAH: Zentiva k.s.. Decision date: 06/06/2024